• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Pharmaceutical Products and CMO Market Research Report 2024(Status and Outlook)

Global Pharmaceutical Products and CMO Market Research Report 2024(Status and Outlook)

  • Category:Life Sciences
  • Published on : 08 October 2024
  • Pages :144
  • Formats:
  • Report Code:24MRES-8011419
Click for best price

Best Price: $2600

The global Pharmaceutical Products and CMO market size was valued at US$ 1.28 trillion in 2024 and is projected to reach US$ 1.67 trillion by 2030, at a CAGR of 4.5% during the forecast period 2024-2030.

United States Pharmaceutical Products and CMO market size was valued at US$ 428.6 billion in 2024 and is projected to US$ 539.7 billion by 2030, at a CAGR of 3.9% during the forecast period 2024-2030.

fallback

Encompasses the development, manufacturing, and distribution of pharmaceutical products, including the services provided by Contract Manufacturing Organizations (CMOs).

Steady growth driven by aging populations and increasing prevalence of chronic diseases. Rising demand for biologics and specialty medicines. Growing outsourcing trend to CMOs for cost-effectiveness and flexibility. Challenges include pricing pressures and stringent regulatory requirements. Emerging focus on personalized medicine and advanced therapies.

Report Overview

This report provides a deep insight into the global Pharmaceutical Products and CMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Products and CMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Products and CMO market in any manner.

Global Pharmaceutical Products and CMO Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

  • Catalent
  • DPx
  • Lonza
  • Piramal Healthcare
  • Aenova
  • Jubilant
  • Famar
  • Boehringer Ingelheim
  • Fareva Holding
  • AbbVie
  • Nipro Corp
  • Vetter
  • Sopharma
  • Mylan (DPT Laboratories)
  • Recipharm
  • NextPharma Technologies
  • Dishman
  • Aesica
  • Including or Excluding key companies relevant to your analysis.

Market Segmentation (by Type)

  • Active Pharmaceutical Ingredient (API)
  • Finished Dosage Form (FDF)
  • Pharmaceutical Packaging

Market Segmentation (by Application)

  • Specialty/Midsize
  • Generics
  • Big Pharma
  • Others

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Pharmaceutical Products and CMO Market
  • Overview of the regional outlook of the Pharmaceutical Products and CMO Market:

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Products and CMO Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmaceutical Products and CMO
1.2 Key Market Segments
1.2.1 Pharmaceutical Products and CMO Segment by Type
1.2.2 Pharmaceutical Products and CMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmaceutical Products and CMO Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmaceutical Products and CMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmaceutical Products and CMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmaceutical Products and CMO Market Competitive Landscape
3.1 Global Pharmaceutical Products and CMO Sales by Manufacturers (2019-2024)
3.2 Global Pharmaceutical Products and CMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmaceutical Products and CMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmaceutical Products and CMO Sales Sites, Area Served, Product Type
3.6 Pharmaceutical Products and CMO Market Competitive Situation and Trends
3.6.1 Pharmaceutical Products and CMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmaceutical Products and CMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmaceutical Products and CMO Industry Chain Analysis
4.1 Pharmaceutical Products and CMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmaceutical Products and CMO Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmaceutical Products and CMO Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmaceutical Products and CMO Sales Market Share by Type (2019-2024)
6.3 Global Pharmaceutical Products and CMO Market Size Market Share by Type (2019-2024)
6.4 Global Pharmaceutical Products and CMO Price by Type (2019-2024)
7 Pharmaceutical Products and CMO Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmaceutical Products and CMO Market Sales by Application (2019-2024)
7.3 Global Pharmaceutical Products and CMO Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmaceutical Products and CMO Sales Growth Rate by Application (2019-2024)
8 Pharmaceutical Products and CMO Market Segmentation by Region
8.1 Global Pharmaceutical Products and CMO Sales by Region
8.1.1 Global Pharmaceutical Products and CMO Sales by Region
8.1.2 Global Pharmaceutical Products and CMO Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmaceutical Products and CMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmaceutical Products and CMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmaceutical Products and CMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmaceutical Products and CMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmaceutical Products and CMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Catalent
9.1.1 Catalent Pharmaceutical Products and CMO Basic Information
9.1.2 Catalent Pharmaceutical Products and CMO Product Overview
9.1.3 Catalent Pharmaceutical Products and CMO Product Market Performance
9.1.4 Catalent Business Overview
9.1.5 Catalent Pharmaceutical Products and CMO SWOT Analysis
9.1.6 Catalent Recent Developments
9.2 DPx
9.2.1 DPx Pharmaceutical Products and CMO Basic Information
9.2.2 DPx Pharmaceutical Products and CMO Product Overview
9.2.3 DPx Pharmaceutical Products and CMO Product Market Performance
9.2.4 DPx Business Overview
9.2.5 DPx Pharmaceutical Products and CMO SWOT Analysis
9.2.6 DPx Recent Developments
9.3 Lonza
9.3.1 Lonza Pharmaceutical Products and CMO Basic Information
9.3.2 Lonza Pharmaceutical Products and CMO Product Overview
9.3.3 Lonza Pharmaceutical Products and CMO Product Market Performance
9.3.4 Lonza Pharmaceutical Products and CMO SWOT Analysis
9.3.5 Lonza Business Overview
9.3.6 Lonza Recent Developments
9.4 Piramal Healthcare
9.4.1 Piramal Healthcare Pharmaceutical Products and CMO Basic Information
9.4.2 Piramal Healthcare Pharmaceutical Products and CMO Product Overview
9.4.3 Piramal Healthcare Pharmaceutical Products and CMO Product Market Performance
9.4.4 Piramal Healthcare Business Overview
9.4.5 Piramal Healthcare Recent Developments
9.5 Aenova
9.5.1 Aenova Pharmaceutical Products and CMO Basic Information
9.5.2 Aenova Pharmaceutical Products and CMO Product Overview
9.5.3 Aenova Pharmaceutical Products and CMO Product Market Performance
9.5.4 Aenova Business Overview
9.5.5 Aenova Recent Developments
9.6 Jubilant
9.6.1 Jubilant Pharmaceutical Products and CMO Basic Information
9.6.2 Jubilant Pharmaceutical Products and CMO Product Overview
9.6.3 Jubilant Pharmaceutical Products and CMO Product Market Performance
9.6.4 Jubilant Business Overview
9.6.5 Jubilant Recent Developments
9.7 Famar
9.7.1 Famar Pharmaceutical Products and CMO Basic Information
9.7.2 Famar Pharmaceutical Products and CMO Product Overview
9.7.3 Famar Pharmaceutical Products and CMO Product Market Performance
9.7.4 Famar Business Overview
9.7.5 Famar Recent Developments
9.8 Boehringer Ingelheim
9.8.1 Boehringer Ingelheim Pharmaceutical Products and CMO Basic Information
9.8.2 Boehringer Ingelheim Pharmaceutical Products and CMO Product Overview
9.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Product Market Performance
9.8.4 Boehringer Ingelheim Business Overview
9.8.5 Boehringer Ingelheim Recent Developments
9.9 Fareva Holding
9.9.1 Fareva Holding Pharmaceutical Products and CMO Basic Information
9.9.2 Fareva Holding Pharmaceutical Products and CMO Product Overview
9.9.3 Fareva Holding Pharmaceutical Products and CMO Product Market Performance
9.9.4 Fareva Holding Business Overview
9.9.5 Fareva Holding Recent Developments
9.10 AbbVie
9.10.1 AbbVie Pharmaceutical Products and CMO Basic Information
9.10.2 AbbVie Pharmaceutical Products and CMO Product Overview
9.10.3 AbbVie Pharmaceutical Products and CMO Product Market Performance
9.10.4 AbbVie Business Overview
9.10.5 AbbVie Recent Developments
9.11 Nipro Corp
9.11.1 Nipro Corp Pharmaceutical Products and CMO Basic Information
9.11.2 Nipro Corp Pharmaceutical Products and CMO Product Overview
9.11.3 Nipro Corp Pharmaceutical Products and CMO Product Market Performance
9.11.4 Nipro Corp Business Overview
9.11.5 Nipro Corp Recent Developments
9.12 Vetter
9.12.1 Vetter Pharmaceutical Products and CMO Basic Information
9.12.2 Vetter Pharmaceutical Products and CMO Product Overview
9.12.3 Vetter Pharmaceutical Products and CMO Product Market Performance
9.12.4 Vetter Business Overview
9.12.5 Vetter Recent Developments
9.13 Sopharma
9.13.1 Sopharma Pharmaceutical Products and CMO Basic Information
9.13.2 Sopharma Pharmaceutical Products and CMO Product Overview
9.13.3 Sopharma Pharmaceutical Products and CMO Product Market Performance
9.13.4 Sopharma Business Overview
9.13.5 Sopharma Recent Developments
9.14 Mylan (DPT Laboratories)
9.14.1 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Basic Information
9.14.2 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Overview
9.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Market Performance
9.14.4 Mylan (DPT Laboratories) Business Overview
9.14.5 Mylan (DPT Laboratories) Recent Developments
9.15 Recipharm
9.15.1 Recipharm Pharmaceutical Products and CMO Basic Information
9.15.2 Recipharm Pharmaceutical Products and CMO Product Overview
9.15.3 Recipharm Pharmaceutical Products and CMO Product Market Performance
9.15.4 Recipharm Business Overview
9.15.5 Recipharm Recent Developments
9.16 NextPharma Technologies
9.16.1 NextPharma Technologies Pharmaceutical Products and CMO Basic Information
9.16.2 NextPharma Technologies Pharmaceutical Products and CMO Product Overview
9.16.3 NextPharma Technologies Pharmaceutical Products and CMO Product Market Performance
9.16.4 NextPharma Technologies Business Overview
9.16.5 NextPharma Technologies Recent Developments
9.17 Dishman
9.17.1 Dishman Pharmaceutical Products and CMO Basic Information
9.17.2 Dishman Pharmaceutical Products and CMO Product Overview
9.17.3 Dishman Pharmaceutical Products and CMO Product Market Performance
9.17.4 Dishman Business Overview
9.17.5 Dishman Recent Developments
9.18 Aesica
9.18.1 Aesica Pharmaceutical Products and CMO Basic Information
9.18.2 Aesica Pharmaceutical Products and CMO Product Overview
9.18.3 Aesica Pharmaceutical Products and CMO Product Market Performance
9.18.4 Aesica Business Overview
9.18.5 Aesica Recent Developments
10 Pharmaceutical Products and CMO Market Forecast by Region
10.1 Global Pharmaceutical Products and CMO Market Size Forecast
10.2 Global Pharmaceutical Products and CMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmaceutical Products and CMO Market Size Forecast by Country
10.2.3 Asia Pacific Pharmaceutical Products and CMO Market Size Forecast by Region
10.2.4 South America Pharmaceutical Products and CMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmaceutical Products and CMO by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pharmaceutical Products and CMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmaceutical Products and CMO by Type (2025-2030)
11.1.2 Global Pharmaceutical Products and CMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmaceutical Products and CMO by Type (2025-2030)
11.2 Global Pharmaceutical Products and CMO Market Forecast by Application (2025-2030)
11.2.1 Global Pharmaceutical Products and CMO Sales (K Units) Forecast by Application
11.2.2 Global Pharmaceutical Products and CMO Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmaceutical Products and CMO Market Size Comparison by Region (M USD)
Table 5. Global Pharmaceutical Products and CMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pharmaceutical Products and CMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmaceutical Products and CMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmaceutical Products and CMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Products and CMO as of 2022)
Table 10. Global Market Pharmaceutical Products and CMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmaceutical Products and CMO Sales Sites and Area Served
Table 12. Manufacturers Pharmaceutical Products and CMO Product Type
Table 13. Global Pharmaceutical Products and CMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmaceutical Products and CMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmaceutical Products and CMO Market Challenges
Table 22. Global Pharmaceutical Products and CMO Sales by Type (K Units)
Table 23. Global Pharmaceutical Products and CMO Market Size by Type (M USD)
Table 24. Global Pharmaceutical Products and CMO Sales (K Units) by Type (2019-2024)
Table 25. Global Pharmaceutical Products and CMO Sales Market Share by Type (2019-2024)
Table 26. Global Pharmaceutical Products and CMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmaceutical Products and CMO Market Size Share by Type (2019-2024)
Table 28. Global Pharmaceutical Products and CMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pharmaceutical Products and CMO Sales (K Units) by Application
Table 30. Global Pharmaceutical Products and CMO Market Size by Application
Table 31. Global Pharmaceutical Products and CMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Pharmaceutical Products and CMO Sales Market Share by Application (2019-2024)
Table 33. Global Pharmaceutical Products and CMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmaceutical Products and CMO Market Share by Application (2019-2024)
Table 35. Global Pharmaceutical Products and CMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmaceutical Products and CMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Pharmaceutical Products and CMO Sales Market Share by Region (2019-2024)
Table 38. North America Pharmaceutical Products and CMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pharmaceutical Products and CMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pharmaceutical Products and CMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Pharmaceutical Products and CMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pharmaceutical Products and CMO Sales by Region (2019-2024) & (K Units)
Table 43. Catalent Pharmaceutical Products and CMO Basic Information
Table 44. Catalent Pharmaceutical Products and CMO Product Overview
Table 45. Catalent Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Catalent Business Overview
Table 47. Catalent Pharmaceutical Products and CMO SWOT Analysis
Table 48. Catalent Recent Developments
Table 49. DPx Pharmaceutical Products and CMO Basic Information
Table 50. DPx Pharmaceutical Products and CMO Product Overview
Table 51. DPx Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. DPx Business Overview
Table 53. DPx Pharmaceutical Products and CMO SWOT Analysis
Table 54. DPx Recent Developments
Table 55. Lonza Pharmaceutical Products and CMO Basic Information
Table 56. Lonza Pharmaceutical Products and CMO Product Overview
Table 57. Lonza Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Lonza Pharmaceutical Products and CMO SWOT Analysis
Table 59. Lonza Business Overview
Table 60. Lonza Recent Developments
Table 61. Piramal Healthcare Pharmaceutical Products and CMO Basic Information
Table 62. Piramal Healthcare Pharmaceutical Products and CMO Product Overview
Table 63. Piramal Healthcare Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Piramal Healthcare Business Overview
Table 65. Piramal Healthcare Recent Developments
Table 66. Aenova Pharmaceutical Products and CMO Basic Information
Table 67. Aenova Pharmaceutical Products and CMO Product Overview
Table 68. Aenova Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Aenova Business Overview
Table 70. Aenova Recent Developments
Table 71. Jubilant Pharmaceutical Products and CMO Basic Information
Table 72. Jubilant Pharmaceutical Products and CMO Product Overview
Table 73. Jubilant Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Jubilant Business Overview
Table 75. Jubilant Recent Developments
Table 76. Famar Pharmaceutical Products and CMO Basic Information
Table 77. Famar Pharmaceutical Products and CMO Product Overview
Table 78. Famar Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Famar Business Overview
Table 80. Famar Recent Developments
Table 81. Boehringer Ingelheim Pharmaceutical Products and CMO Basic Information
Table 82. Boehringer Ingelheim Pharmaceutical Products and CMO Product Overview
Table 83. Boehringer Ingelheim Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Recent Developments
Table 86. Fareva Holding Pharmaceutical Products and CMO Basic Information
Table 87. Fareva Holding Pharmaceutical Products and CMO Product Overview
Table 88. Fareva Holding Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Fareva Holding Business Overview
Table 90. Fareva Holding Recent Developments
Table 91. AbbVie Pharmaceutical Products and CMO Basic Information
Table 92. AbbVie Pharmaceutical Products and CMO Product Overview
Table 93. AbbVie Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AbbVie Business Overview
Table 95. AbbVie Recent Developments
Table 96. Nipro Corp Pharmaceutical Products and CMO Basic Information
Table 97. Nipro Corp Pharmaceutical Products and CMO Product Overview
Table 98. Nipro Corp Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Nipro Corp Business Overview
Table 100. Nipro Corp Recent Developments
Table 101. Vetter Pharmaceutical Products and CMO Basic Information
Table 102. Vetter Pharmaceutical Products and CMO Product Overview
Table 103. Vetter Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Vetter Business Overview
Table 105. Vetter Recent Developments
Table 106. Sopharma Pharmaceutical Products and CMO Basic Information
Table 107. Sopharma Pharmaceutical Products and CMO Product Overview
Table 108. Sopharma Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sopharma Business Overview
Table 110. Sopharma Recent Developments
Table 111. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Basic Information
Table 112. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product Overview
Table 113. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Mylan (DPT Laboratories) Business Overview
Table 115. Mylan (DPT Laboratories) Recent Developments
Table 116. Recipharm Pharmaceutical Products and CMO Basic Information
Table 117. Recipharm Pharmaceutical Products and CMO Product Overview
Table 118. Recipharm Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Recipharm Business Overview
Table 120. Recipharm Recent Developments
Table 121. NextPharma Technologies Pharmaceutical Products and CMO Basic Information
Table 122. NextPharma Technologies Pharmaceutical Products and CMO Product Overview
Table 123. NextPharma Technologies Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. NextPharma Technologies Business Overview
Table 125. NextPharma Technologies Recent Developments
Table 126. Dishman Pharmaceutical Products and CMO Basic Information
Table 127. Dishman Pharmaceutical Products and CMO Product Overview
Table 128. Dishman Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Dishman Business Overview
Table 130. Dishman Recent Developments
Table 131. Aesica Pharmaceutical Products and CMO Basic Information
Table 132. Aesica Pharmaceutical Products and CMO Product Overview
Table 133. Aesica Pharmaceutical Products and CMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Aesica Business Overview
Table 135. Aesica Recent Developments
Table 136. Global Pharmaceutical Products and CMO Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Pharmaceutical Products and CMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Pharmaceutical Products and CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Pharmaceutical Products and CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Pharmaceutical Products and CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Pharmaceutical Products and CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Pharmaceutical Products and CMO Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Pharmaceutical Products and CMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Pharmaceutical Products and CMO Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Pharmaceutical Products and CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Pharmaceutical Products and CMO Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Pharmaceutical Products and CMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Pharmaceutical Products and CMO Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Pharmaceutical Products and CMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Pharmaceutical Products and CMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Pharmaceutical Products and CMO Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Pharmaceutical Products and CMO Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Pharmaceutical Products and CMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical Products and CMO Market Size (M USD), 2019-2030
Figure 5. Global Pharmaceutical Products and CMO Market Size (M USD) (2019-2030)
Figure 6. Global Pharmaceutical Products and CMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmaceutical Products and CMO Market Size by Country (M USD)
Figure 11. Pharmaceutical Products and CMO Sales Share by Manufacturers in 2023
Figure 12. Global Pharmaceutical Products and CMO Revenue Share by Manufacturers in 2023
Figure 13. Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmaceutical Products and CMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Products and CMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmaceutical Products and CMO Market Share by Type
Figure 18. Sales Market Share of Pharmaceutical Products and CMO by Type (2019-2024)
Figure 19. Sales Market Share of Pharmaceutical Products and CMO by Type in 2023
Figure 20. Market Size Share of Pharmaceutical Products and CMO by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmaceutical Products and CMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmaceutical Products and CMO Market Share by Application
Figure 24. Global Pharmaceutical Products and CMO Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmaceutical Products and CMO Sales Market Share by Application in 2023
Figure 26. Global Pharmaceutical Products and CMO Market Share by Application (2019-2024)
Figure 27. Global Pharmaceutical Products and CMO Market Share by Application in 2023
Figure 28. Global Pharmaceutical Products and CMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmaceutical Products and CMO Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pharmaceutical Products and CMO Sales Market Share by Country in 2023
Figure 32. U.S. Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pharmaceutical Products and CMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmaceutical Products and CMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pharmaceutical Products and CMO Sales Market Share by Country in 2023
Figure 37. Germany Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pharmaceutical Products and CMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmaceutical Products and CMO Sales Market Share by Region in 2023
Figure 44. China Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pharmaceutical Products and CMO Sales and Growth Rate (K Units)
Figure 50. South America Pharmaceutical Products and CMO Sales Market Share by Country in 2023
Figure 51. Brazil Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pharmaceutical Products and CMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmaceutical Products and CMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pharmaceutical Products and CMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pharmaceutical Products and CMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pharmaceutical Products and CMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmaceutical Products and CMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmaceutical Products and CMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmaceutical Products and CMO Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmaceutical Products and CMO Market Share Forecast by Application (2025-2030)

SELECT A FORMAT

USD GBP EURO YEN Single User License
USD GBP EURO YEN Multi User License
USD GBP EURO YEN Corporate User License

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount